19/03/2026
Not really the same… but kind of the same - biosimilars!🧬👯♂️
Twins and biosimilars share one important principle: similarity without being identical. In highly regulated fields like medicine, that distinction truly matters – particularly when it comes to biologic therapies and improving access to high-quality, proven treatments.
What exactly are biosimilars – and why does that similarity matter?
Our colleague Alexey Chekmarev, Commercial Director Global Specialty at STADA, breaks it down in the video below. 👇